Navigation Links
Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
Date:2/23/2012

ROCKVILLE, Md., Feb. 23, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate in three upcoming investor conferences.

On Tuesday, February 28, 2012, Mihael Polymeropoulos, M.D., Vanda's President and CEO, will participate in a Neurology-focused discussion at RBC Capital Markets' Global Healthcare Conference in New York City.

On Wednesday, February 29, 2012, Dr. Polymeropoulos will deliver a corporate presentation at Citi's 2012 Global Health Care Conference at 2:00 pm Eastern Time in New York City. 

The Citi conference presentation will be available live on Vanda's corporate website, where it will be archived for 30 days.  To access this presentation, log on to http://www.vandapharma.com and click on the "Presentations" option in the Investor Relations section.  Please connect to the website several minutes prior to the start of the live presentation.

On Monday, March 5, 2012, Dr. Polymeropoulos will deliver a corporate presentation at Cowen and Company's 32nd Annual Health Care Conference in Boston.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Senior Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com

 


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results
2. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel
3. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
4. Vanda Pharmaceuticals Appoints Chief Commercial Officer
5. Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
6. Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
7. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
8. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
10. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... generation. Yisrayl makes an astounding statement when he says that the entire Bible ... Bible details the current times so plainly that anyone should be able to see ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, a national ... , media relations, social media, content marketing and SEO, is now offering direct, ... an intuitive marketing automation platform. , Rosica will now offer the platform to ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, 2017 ... letter to withdraw previous guidance issued by the Obama Administration requiring schools ... in May 2016 by the Obama Administration came in response to a growing ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is ... KLS is a longtime supporter of the event. , "We are pleased that ... said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
Breaking Medicine News(10 mins):